Table 4.
Infection rates and adjusted HRs for PCR-confirmed infection after the first dose of vaccine, by vaccine type and days since vaccination (secondary analysis)
|
ChAdOx1 |
BNT162b2 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Person-days at risk | Infection events | Infection rate per 10 000 person-days | Adjusted HR (95% CI) | p value | Person-days at risk | Infection events | Infection rate per 10 000 person-days | Adjusted HR (95% CI) | p value | |
| Unvaccinated | 338 003 | 723 | 21·39 | 1 (ref) | .. | .. | .. | .. | 1 (ref) | .. |
| 0–6 days | 30 823 | 61 | 19·79 | 0·51 (0·26–0·99) | 0·045 | 16 768 | 44 | 26·24 | 0·84 (0·39–1·81) | 0·663 |
| 7–13 days | 34 598 | 66 | 19·08 | 0·58 (0·35–0·96) | 0·035 | 18 913 | 73 | 38·60 | 1·11 (0·65–1·88) | 0·700 |
| 14–20 days | 32 672 | 82 | 25·10 | 0·95 (0·50–1·84) | 0·889 | 17 690 | 50 | 28·26 | 0·77 (0·37–1·58) | 0·473 |
| 21–27 days | 30 640 | 50 | 16·32 | 0·73 (0·37–1·44) | 0·358 | 16 874 | 45 | 26·67 | 0·94 (0·50–1·79) | 0·859 |
| 28–34 days | 27 041 | 23 | 8·51 | 0·33 (0·16–0·68) | 0·0025 | 16 095 | 19 | 11·80 | 0·47 (0·20–1·06) | 0·070 |
| 35–48 days | 34 705 | 36 | 10·37 | 0·32 (0·15–0·66) | 0·0023 | 28 307 | 23 | 8·13 | 0·35 (0·17–0·71) | 0·0038 |
| ≥49 days | 7421 | 16 | 21·56 | 0·64 (0·26–1·56) | 0·329 | 20 078 | 24 | 11·95 | 0·38 (0·15–0·93) | 0·034 |
| Total (vaccine type) | 197 900 | 334 | 16·88 | .. | .. | 134 725 | 278 | 20·63 | .. | .. |
Adjusted HRs were estimated using Cox proportional hazards regression according to days since the first vaccine dose for each vaccine type (ChAdOx1 and BNT162b2). The comparator was the unvaccinated group. HRs were adjusted for age, sex, local monthly infection incidence, and long-term care facility bed capacity. 95% CIs were calculated using robust standard errors for long-term care facility-level effects. HR=hazard ratio.